Jiang et al. reported that CYP2J2 mRNA and protein levels are upregulated, to varying degrees, in eight different tumor derived cell lines, including A549 from lung cancer, compared to non-cancerous cells (Jiang et al., 2005). The gene discussed is CYP2J2; the disease is neoplasm.